Virtual Medicinal Product (VMP)
-
Triptorelin embonate 11.25mg powder and solvent for suspension for injection vials
Name Details
Current Name
Triptorelin embonate 11.25mg powder and solvent for suspension for injection vials
|
Start Date
14-01-2011
|
End Date
|
|
Abbreviated Name
Triptorelin embonate 11.25mg inj vials
|
Start Date
14-01-2011
|
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intramuscular
- Form
- Powder and solvent for suspension for injection
- Ontology Form/Route
- suspensioninjection.intramuscular
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- INNM - International Non-proprietary Name (Modified)
Codes
- ATC Code
-
L02AE04
BNF |
Current BNF
08030402
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
06070200
|
Start Date
30-01-2012
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
18468411000001108 |
14-01-2011 |
|
VMP Ingredients
Name
Triptorelin embonate
Basis of strength description
Based on Base Substance
BOSS
Triptorelin
Strength and UOM (Nmr)
11.25
Strength and UOM (Dmr)
Parent Products
-
VTM
Triptorelin
-
VMP
(Current) Triptorelin embonate 11.25mg powder ...
Virtual Medicinal Product Pack (VMPP) Information